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Abstract
Background: Public hospitals in China play an important role in tuberculosis (TB) control. Three models of hospital
and TB control exist in China. The dispensary model is the most common one in which a TB dispensary provides
both clinical and public health care. The specialist model is similar to the former except that a specialist TB hospital
is located in the same area. The specialist hospital should treat only complicated TB cases but it also treats simple
cases in practice. The integrated model is a new development to integrate TB service in public hospitals. Patients
were diagnosed, treated and followed up in this public hospital in this model while the TB dispensary provides
public health service as case reporting and mass education. This study aims to compare patient care seeking
pathways under the three models, and to provide policy recommendation for the TB control system reform in
China.
Methods: Six sites, two in each model, were selected across four provinces, with 293 newly treated uncomplicated
TB patients being randomly selected.
Results: The majority (68%) of TB patients were diagnosed in hospitals. Patients in the integrated model presented
the simplest care seeking pathways, with the least number of providers visited (2.2), shortest treatment delays
(2 days) and the least medical expenditure (2729RMB/401USD). On the contrary, patients in the specialist model
had the highest number of provider visits (4), longest treatment delays (23 days) and the highest medical
expenditure (11626RMB/1710USD). Logistic regression suggested that patients who were hospitalised tended to
have longer treatment delays and higher medical expenditure.
Conclusion: Specialist hospital treating uncomplicated cases not using the standard regimens posed a threat to TB
control. The integrated model has shortened patient treatment pathways, and reduced patient costs; therefore, it
could be considered as the direction for future reform of China’s TB control system.
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Background
Tuberculosis (TB) is a global public health threat, with 8.7
million TB patients and 1.4 million deaths due to TB
estimated in 2011. Over 95% of TB deaths occurred in low
and middle income countries [1]. Global TB control
adopts a systematic care approach called DOTS (Directly
Observed Therapy, Short-Course) programme, which has
been recommended by the World Health Organisation
(WHO) since the 1990s. The DOTS programme has been
largely implemented by public sectors under national TB
programmes (NTPs). However, many patients seek care
from a variety of health providers, often outside of the
NTP’s TB clinics. These providers include public hospitals,
corporate health services, private clinics and hospitals [2].
In many developing countries, the public-private/public
mix (PPM) approach were promoted to extend effective
standard TB care from the NTP clinics to all other
providers [3]. Studies have demonstrated the PPM strategy
has contributed to detecting more TB patients, reaching a* Correspondence: qiangs@sdu.edu.cn3Center for Health Management and Policy, Shandong University, Mailbox
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wider population, and achieving better treatment outcomes
[4-6], as well as being cost effective at the same time [7-9].
In China, public hospital is the largest healthcare pro-
vider, but it is often not part of the NTP. China’s NTP is
organised in a semi-vertical system by TB dispensaries at
four levels: national, provincial, prefecture and county/
district. The majority of patients are diagnosed and
treated at the district/county TB dispensary, usually a
department located in the local Centre for Disease
Control. TB dispensaries at higher levels mostly provide
programme administration, case reporting and service
supervision. Free TB DOTS service is provided in TB
dispensaries, covering costs of the first-line anti-TB
drugs, two X-ray examinations and all sputum smear
examinations [10]. Patients who seek care outside of TB
dispensaries are not covered by the free treatment
policy. Historically, there was a lack of coordination
between public hospitals and the NTP in China, resulting
in patients’ long diagnostic delays, poor treatment
outcomes and high patient financial burdens [11]. The
2000 national TB survey reported that 91% of TB patients
visited public hospitals first to treat TB related symptoms,
while only 25% of TB suspects in public hospitals were
referred to TB dispensaries [12]. Recent studies reported
that over 70% of TB patients in public hospitals were not
referred to TB dispensaries [13], while many patients spent
over half of their annual income in public hospitals before
their TB diagnoses [14-16].
The government has promoted hospital and TB collabo-
ration since 2006 [17]. Under the WHO PPM framework,
three models of hospitals and TB collaboration in China
are identified. The dispensary model is the most common
one in which TB dispensaries provide all TB care regarding
diagnosis, treatment, clinical management, as well as health
education, supervision and case reporting. Public hospitals
are responsible to refer TB cases to TB dispensaries,
and TB dispensaries should trace all referred cases
who have not visited the dispensary within three days.
Only complicated and severe TB cases should be
treated in general hospitals. The specialist model is
similar to the former except that a specialist TB hospital is
located in the same area. The specialist hospital should only
treat severe TB cases according to national guidelines and
refer uncomplicated patients to the TB dispensary [18].
This model exists mostly in north China and some provin-
cial capitals. The integrated model is a new initiative to
integrate TB care within public hospitals. A clinic is set up
in a general hospital to provide TB clinical care. The
hospital becomes known as a TB designated hospital. TB
patients are diagnosed, treated and followed-up in the
designated hospital. In this model, the TB dispensary is
responsible for TB public health care, including training,
education, case supervision, cohort analysis and reporting.
Other public hospitals should refer TB suspects and
patients to the designated hospital. This model has been
practiced in Shanghai, Zhejiang and Jiangsu provinces, and
a few sites in less developed western provinces.
Current policy debates were regarding which model
fits into China’s future TB control, because the TB
dispensary is not prepared for the emerging of multi-drug
resistance (MDR) TB, TB/HIV and other complicated cases.
Furthermore, the dispensary model was at stake after the
enactment of the Law for Licensing Medical Practitioners
which banning public health doctors in TB dispensaries
providing clinical care [19]. The study aims to analyse
and compare the care-seeking pathways and medical
expenditureof TB patients under the three hospital
TB collaboration models in China, and to provide




A cross-sectional survey was conducted in the six sites of
China. Two sites of each model were suggested by the
national and provincial TB programmes, with one relatively
rich, and the other relatively poor. Two sites of the
integrated sites were selected in Shanghai (east) and
Guangxi (west) because the integrated model was new in
China and both sites had been established by local health
authorities over three years. Two of the specialist sites were
selected in Shandong province, as this model was most
popular in northern China. For the dispensary model, one
site in Zhejiang (east) and the other in Guangxi (west) were
selected. Each site consists of a county or a district
where the basic TB management unit is located.
National TB guidelines have been implemented across all
China; therefore, standard TB diagnosis and treatment
should be provided in all six sites [20].
Study participants
Due to the availability of TB cases, we randomly selected
50 TB patients in each site from the TB dispensary
registers according to the inclusion criteria: 1) being new
sputum smear positive or negative pulmonary TB patients,
2) been registered in 2007 and successfully completed
treatment by August 2008; 3) having no records on any
serious co-morbidities such as diabetes, cardiovascular
disease, hepatic disease or severe respiratory symptoms.
All selected cases treated by the specialist hospitals were
negative in drug sensitivity tests. Drug sensitivity tests
were not available to TB patients in other models. But we
selected cases which had been successfully treated, so they
were not likely to be drug resistant.
Data collection
Subjects were surveyed using a structured questionnaire
adapted from the National TB patient survey [12], which
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had been used in other similar settings [14,21]. Questions
covered patient social-economic status, experience of TB
diagnosis and related treatment, patient expenditure on TB
related treatment, i.e., excluding any coverage from insur-
ances, and delays. Patients were selected by a random
number from the TB registers, and then were invited to
the place where they were treated before, i.e., the TB
dispensary, the specialist hospital or the TB designated
hospital. A free consultation was provided as an incentive.
Taking consideration that 10% of patients may not come to
the survey, each site invited 55 patients. In total, 293
patients were surveyed, including 100 in the dispensary
sites (51 from the rich site and 49 from the poor site), 90
in the specialist sites (44 and 46, respectively) and 103 in
the integrated sites (50 and 53, respectively).
Ethical approval was granted by the Ethical Committee
for Health Policy Studies located in Shandong University.
Written informed consents have been obtained from
all participants in the study. Data were collected by a
team of experienced researchers and postgraduate
students in 2008.
Analysis
SPSS 14.0 (Chicago, USA) was used for analysis. Chi-
square test, Kruskal-Wallis H test and ordinal data
analysis were employed when appropriate. Logistic regres-
sion was employed to identify factors related with
treatment delay (0 = ≤7 days; 1 = >7 days) and medical
expenditure (0 = ≤3000 RMB/ 441 USD; 1 = >3000 RMB).
Independent variables were selected based on individual
regression with the dependant variables at the significant
level of α = 0.1 and their theoretical relevance.
Dummy variables were generated for variables having
more than 2 values. The two logistic models were
statistically significant (model coefficient tests P < 0.05)
and showed a good model fitness (Hosmer and Lameshow
tests, P > 0.90).
We defined the place of actual TB diagnosis as where
the patient was first informed of TB with sputum micros-
copy examined. Treatment delay refers to the period after
TB diagnosis and before the standard DOTS chemother-
apy initiated in TB dispensaries or designated hospitals.
Treatment delay is considered long if over one week [13].
We also examined diagnosis delay, which is defined as the
period from the first healthcare contact until the patient’s
TB diagnosis. We used 3000RMB/441USD as the cut-off
point of medical expenditure in the logistic regression as
3000RMB is the median medical expenditure of all
patients. Health providers were grouped as primary care
facilities (village doctors, township hospitals and commu-
nity health centres), hospitals, specialist hospitals, TB dis-
pensaries or TB designated hospitals. Repeated visits to
the same health provider, e.g., renewing drugs, were
accumulated and regarded as one visit in the pathway
map; however, different diagnoses with the same provider
were accounted as different visits to highlight a possible
delay during the care.
Results
Of the 293 patients participated in the study, the average
age were 47 years old. Per capita income was the highest
in the integrated model. The majority of patients in the
dispensary and specialist sites were farmers. Most
patients were covered by insurance such as the basic
health insurance in urban areas and the new cooperative
medical insurance scheme in rural areas (Table 1).
Patient pathways until treatment completion
On average, a patient in the specialist model visited four
health providers until treatment completion compared
with only 2.2 providers for a patient in the integrated
model (P < 0.01). Over 70% of patients in the dispensary
and integrated models visited one provider until diagno-
sis of TB (Table 2). The majority (68%) of TB patients
Table 1 General information of patients participated in the survey under the three models
The dispensary model The specialist model The integrated model
Patients survey 100 90 103
Average age x (95%CI) 53 (49.6-56.1)a 46 (41.8-49.8) 42 (38.8-45.1)
Male, N (%) 62 (62) 62 (69) 65 (63)
Married, N (%) 79 (79) 58 (64) 72 (70)
Farmer, N (%) 67 (67) 51 (57) 24 (23)b
With medical insurance, N (%) 94 (94) 82 (91) 77 (75)
Per capita annual income (RMB) x (95%CI) 5,146 (3481-6811) 4,226 (2930-5523) 11,197 (8516-13878)c
1 USD = 6.8 RMB.
a Kruskal-Wallis H test showed that significant difference was found among three models (χ2 = 36.448, P<0.001). The average age of patients in the dispensary
model was significantly higher than that in the specialist model (P = 0.003) and the integrated model (P<0.001).
b Significant lower than the dispensary model (χ2 = 39.176, P<0.001) and the specialist model (χ2 = 22.506, P<0.001).
c Kruskal-Wallis H test showed that significant difference was found among three models (χ2 = 21.056, P<0.001). Per capita income of patients in the integrated
model was significantly higher than that in the dispensary model (P<0.001) and the specialist model (P<0.001).
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were diagnosed in public hospitals: 37% of patients in the
dispensary model were diagnosed in general hospitals,
56% in the specialist model were diagnosed in specialist
hospitals, and 93% in the integrated model were diagnosed
in the designated hospitals.
In the dispensary model (Figure 1), 52% (52) of patients
used general hospitals as their first contact of care, because
of the perceived high quality (75%, 39/52) of the general
hospitals. Thirty-eight percent of patients firstly visited
primary care facilities such as township hospitals or
village doctors, while 10% firstly visited the county TB
dispensary. All the 78 patients who visited the general
hospital were referred to TB dispensaries, but 47% of them
were hospitalised before the referral.
In the specialist model (Figure 2), 52% (47) of patients
firstly visited primary care facilities for convenience reasons
(77%, 36/47). Thirty-three percent firstly visited general
hospitals, while 13% firstly visited the specialist hospital. Of
the 60 patients who visited general hospitals, 68%
continued to visit specialist hospitals. The majority (92%,
66/72) who visited specialist hospitals were hospitalised
there. Only 47% (34/72) were referred to the TB dispen-
saries. Ten patients visiting the TB dispensaries continued
seeking treatment in the specialist hospitals due to the
latter’s high fame in TB care.
In the integrated model (Figure 3), 28% (29/103) firstly
visited the TB designated hospitals, while 45% (46/103) of
patients started their first treatment in other general
hospitals. Reasons of visiting the TB designated hospital
included perceived high quality of care and closeness to
patient’s homes. All the 58 patients who visited other gen-
eral hospitals were referred to the TB designated hospitals,
but 25% were hospitalised in these hospitals before being
referred to the designated hospital.
Table 3 showed that patients who visited hospitals had
higher medical expenditure than those who did not, as
shown in the dispensary and specialist models (patients
pathways 1, 2 vs. patients pathways 3,4,5,6, P < 0.05). In
the specialist model, patients who only received care in
the specialist hospital spent much more expenses than
those who received DOTS treatment in TB dispensaries
(patients pathways 5 and 6 vs. other patients pathways,
P < 0.05). Patients who visited primary care facilities had
longer diagnostic delay than patients who did not in all
the three models (P < 0.001). Average medical expen-
diture were the highest in the specialist model (RMB
11626/USD 1710, P < 0.01) and the lowest in the
integrated model (RMB 2729/USD 401, P < 0.01).The
delays were significantly shorter in the integrated model
compared with that in the dispensary model and the
specialist model (P < 0.05).
Factors related with treatment delay and medical
expenditure
Table 4 listed all the variables included in the logistic
regressions, while Table 5 showed the significant variables
Table 2 Number of health providers visited from first contact of care until treatment completion by TB patients in the
three models
The dispensary model The specialist model The integrated model
Patient survey 100 90 103
Total health providers per patient visited 2.6 4.0a 2.2
1-2 times (%) 51 (51) 16 (18) 75 (73)
>2 times (%) 49 (49) 74 (82) b 28 (27)
Health providers per patient visited before diagnosis 1.1 1.8 1.0
1 times (%) 70 (70) 43 (48) 82 (80)
>1 times (%) 30 (30) 47 (52)c 23 (22)
a Kruskal-Wallis H test showed that significant difference was found among three models (χ2 = 85.962, P<0.001). Patients in the specialist model visited more
health providers than patients in the dispensary model (P<0.001), and so was the dispensary model compared with the integrated model (P = 0.005).
b Proportion of over 2 times in the specialist model was significantly higher than that in the dispensary model (χ2 = 22.902, P<0.001), and the proportion in the
dispensary model was significantly higher than that in the integrated model (χ2 = 10.257, P = 0.001).
c The proportion in the specialist model was significantly higher than that in the dispensary model (χ2 = 9.705, P = 0.002) and the integrated model
(χ2 = 19.357, P<0.001).









Figure 1 Care pathways of 100 tuberculosis (TB) patients in the dispensary model from first contact care until treatment completion.
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included in the logistic regression models and their odds
ratios. After adjusting demographic and socio-economic
factors, patients in the specialist model were more likely to
have treatment delays longer than one week and had
higher medical expenditure. Patients who were hospitalised
tended to have treatment delays longer than one week and
higher medical expenditure. Patients who visited general
hospitals or the TB specialist hospitals tended to have
longer treatment delays.
Discussion
Evidence from the study suggested that patients of the
integrated model had the simplest care pathways,
reflected by the least number of providers visited and
the least medical expenditure spent. Early symptoms of
TB are non-specific, including cough, fever and weigh
loss. They are often similar to other common respiratory
diseases such as pneumonia. Patients usually seek care
from general hospitals rather than the TB dispensary for
these symptoms [22]. The integrated model provides TB
clinical service in a general hospital, therefore, TB patients
seeking care in the hospital can be treated more promptly,
and not needed to be referred to the TB dispensaries as
per other two models.
Patients in the specialist model had the most complicated
patient pathways, reflected by the highest number of health
providers visited and the highest medical expenditure. TB
specialist hospitals are responsible to treat sophisticated TB
cases, such as extra-pulmonary TB, multi-drug resistance
cases and cases with complications [20]. All patients in this
study were uncomplicated TB cases, and should be
treated in the district/county TB dispensary. However,
80% of them were treated in the TB specialist
hospitals. One possible reason may be the perceived
high quality of the specialist hospital. The specialist
hospital may induce more demand as well, because
over 70% of hospital revenues came from treating TB
patients [23,24]. Therefore, specialists hospitals have
the incentive to over-treatment TB patients, and are
reluctant to refer patients out.
The logistic regression identified hospitalisation, often
unnecessary for uncomplicated TB cases, were the most
significant factor associated with longer treatment delays
and higher medical expenditure. We found that a signifi-
cant proportion of patients were hospitalised across the
three models. This reflected the public hospitals in China
still have the financial incentive to over-treat TB patients
despite of the strengthened case reporting system [25].
Internationally, unnecessary and suboptimal TB treatment
were also found in large hospitals in Asian and African
countries, including unnecessary hospitalisation, not using
the DOTS regiment and not referring patients to the na-
tional TB programme [26-28]. This needs close attention of
the international TB community because improper treat-
ment such as discontinuation of DOTS regiments and early
application of second line anti-TB drugs in the hospitals
may lead to the emergence or amplification of multi-drug
resistance TB [29].
China’s TB control is at a cross-road again after 20 years
development through the DOTS program. TB clinical
service in the TB dispensary has to be shifted to hospitals,
because the Law of Licensing Medical Practitioners was

















Figure 2 Care pathways of 90 tuberculosis (TB) patients in the specialist model from first contact of care until treatment completion.










Figure 3 Care pathways of 103 tuberculosis (TB) patients in the integrated model from first contact of care until treatment completion.
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Table 3 Patient major care pathways, their medical expenditure and delays in the three models of hospital and TB linkages in China


































1.CTD/TDH 10 (10) 3663 11 (2) 5 (1) 1 (1) 2700 11 4 29 (28) 2296 3 (1) 2 (1)
2.PCF→ CTD/TDH 12 (12) 3036 102 (30) 6 (1) 6 (7) 2353 25 (16) 0 (0) 16 (16) 2189 6 (2) 1 (1)
3.Hospital→ CTD/TDH 52 (52) 5055 15 (2) 9 (1) 22 (24) 10029 8 (1) 20 (15) 46 (45) 2512 12 (2) 3 (1)
4.PCF→Hospital→ CTD/TDH 26 (26) 4972 53 (10) 25 (8) 23 (26) 11373 52 (20) 32 (8) 12 (12) 5327 33 (25) 3 (1)
5.Specilaist Hospital* 0 20(22) 9547 2 (1) - 0
6.PCF→ Specialist Hospital* 0 18 (20) 19798 29 (9) - 0
Total 100 4652 35 (4) 12 (1) 90 11626a 23 (6) 23 (0) 103 2729 11 (1)b 2 (1)c
PCF: Primary care facilities, including village doctor clinics and community health centres or township hospitals.
CTD: county TB dispensaries; TDH: TB designated hospitals.
Hospital: here including general hospitals and TB special hospital, but excluding TB designated hospitals.
* For patients finished their treatment in the specialist hospitals, including pathways from general hospital to the TB special hospital and from primary care facilities to general hospital, then to the TB special hospital.
a Kruskal-Wallis H test showed that significant difference was found among three models (χ2 = 83.268, P<0.001). The specialist model was significantly higher than the dispensary model (P<0.001), and the dispensary
model was significantly higher than the integrated model (P = 0.034).
b Kruskal-Wallis H test showed that significant difference was found among three models (χ2 = 17.042, P<0.001).. The integrated model was significantly shorter than the dispensary model (P = 0.001) and the specialist
model (P = 0.002).
c Kruskal-Wallis H test showed that significant difference was found among three models (χ2 = 9.283, P<0.001). The integrated model was significantly shorter than the dispensary model (P = 0.024) and the specialist



















issued, and also because the TB dispensary was generally
lack of clinical competences. One argument is to shift all
TB treatment to specialist hospitals where available. Our
study suggested the potential serious consequences. On
the other hand, the study suggesting shift TB clinical ser-
vice to general hospitals should be a better solution. One
worry is that the designated hospitals may over-test and
treat patients for profit reasons, as public hospitals may do
in the TB dispensary model [22,30]. We found that treat-
ment of TB patients in designated hospitals was in better
compliance with national guidelines. This may because of
the relatively small number of TB patients compared with
of the total patients in the designated hospital. We believe
that better government support and regulation enforcement
should play a major role in our selected sites. Local govern-
ment should provide staff salaries and operational costs of
the TB clinic in the designated hospital; while the TB dis-
pensary should have a close monitoring and evaluation of
case management in the designated hospitals, as outlined in
the PPM model [31]. The integrated model has been
piloted in poorer western provinces with financial support
from the Global Fund. The ceasing of Global Fund
support in China in 2013 will pose a threat to the de-
velopment of integrated model because the local gov-
ernment in poorer provinces may not substitute the
essential financial support.
Previous studies in China indicated that financial
constraints, rural residence and other socio-demographic
Table 4 Dependent and independent values for logistic regression models
Indicators Category
values Treatment delay 0 = ≤ 1 week; 1 = > 1 week
Medical expenditure 0 = ≤ 3000 RMB; 1 = > 3000 RMB
Independent variables
Gender: 0 = female; 1 =male
Age group: 0 = ≤24 years; 1 = 25-59 years; 2 =≥60 years
Marital status 0 = single; 1 =married
Profession: 0 = farmer; 1 = else
Annual per capita income: 0 = the lower 50% income group; 1 = the higher 50 % income
If having medical insurance: 0 = no; 1 = yes
Hospitalisation: 0 = no; 1 = yes
Number of health providers visited: 0 = ≤2 times; 1 = >2 times
If first contact as a primary care facility: 0 = no; 1 = yes
If visited a general hospital or specialist hospital: 0 = no; 1 = yes
Group:
0 = the integrated model; 1 = the dispensary model; 2 = the
specialist model
Diagnostic delays*: 0 = ≤ 2 weeks; 1 = > 2 weeks
Treatment delays*: 0 = ≤ 1 week; 1 = > 1 week
* Only in the regression model of medical expenditure.
Table 5 Significant independent variables in the two logistic regression models
Dependent variables Independent variables in the equation Odds ratio (95% CI) P value
Treatment delay Group (comparing with the integrated model) 0.094
- The specialist model 4.25 (1.12-16.17) 0.034
- The dispensary model 3.41 (.98-11.78) 0.053
Hospitalization 9.74 (4.15-22.83) <0.001
Visited the general or TB special hospital 5.23 (1.06-25.91) 0.043
Medical expenditure Group (comparing with the integrated model) 0.026
- The specialist model 2.75 (0.97-8.17) 0.038
Number of health providers visited 5.38 (2.58-11.23) <0.001
Hospitalization 21.52 (6.04-76.70) <0.001
Treatment delay 5.42 (1.72-17.06) 0.004
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factors affected delays in diagnosis and treatment of TB
[22,32]. Other policy options may also be explored to im-
prove the accessibility of TB care. Decentralising the TB
care from the county level to the community level has
demonstrated shortened TB patient care-seeking pathways,
reduced patient costs, and improved quality of TB care in
China [14,33].
Several limitations have to be borne in mind. Only two
sites in each model were selected in the study, great
cautions should be taken in extrapolation the results of
this study. Substantial variations on income among sites
should be taken with caution and may influence results.
The two sites in the integrated model were richer than
other sites, mainly due to the reason that the majority of
established integrated models were only available from
more developed provinces or rich areas in the relatively
less developed provinces at the time of the study. This
may indicate that government support was essential for
a functional integrated model. Patient reporting on
income, expenditure, and time may suffer from validity
problems due to recall bias. The problem was minimised
as most interviews were taken within half a year after
treatment completion.
Conclusion
Specialist hospital treating uncomplicated cases not using
the standard regimens posed a threat to TB control. The
integrated model has shortened patient treatment path-
ways, and reduced patient costs; therefore, it could be
considered as the direction for future reform of China’s
TB control system.
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